Bogdan J A, Apicella M A
Department of Medicine and Microbiology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo 14215, USA.
Infect Immun. 1995 Nov;63(11):4395-401. doi: 10.1128/iai.63.11.4395-4401.1995.
P6 is an outer membrane protein of Haemophilus influenzae that is antigenically conserved and considered a candidate component of future H. influenzae vaccines. P6 contains a surface-exposed epitope recognized by monoclonal antibody (MAb) 3B9. This epitope has been shown to be distinct from that recognized by the P6-specific MAbs 7F3 and 4G4 in a competitive inhibition enzyme-linked immunosorbent assay (ELISA). MAb 3B9 did not bind to synthetic P6-specific sequential and overlapping hexameric peptides. Five peptides made to correspond to P6 sequences with high probabilities of surface exposure did not inhibit binding of MAb 3B9 to P6. An antiserum to one of the peptides, designated SP66, inhibited binding of MAb 3B9 to P6. A rabbit antiserum to P6 bound to sequential hexameric peptides, Gly-87AsnThrAspGluArgGlyThr-94, which were in the SP66 region of P6. This antiserum inhibited the binding of P6 to MAb 3B9 in a competitive inhibition ELISA. P6 mutations with His and Ala substitutions at residues Thr-88 and Asn-89 still bound MAb 3B9. MAb 3B9 reacted with Escherichia coli OmpA and Salmonella typhimurium OmpA. Sequence comparisons of P6 with these proteins indicated that the residue in the SP66 region responsible for binding is either Gly-87, Asp-90, or Gly-93. Mercaptoethanol reduction abolished MAb 3B9 binding to E. coli OmpA and S. typhimurium OmpA. In these proteins, immediately downstream of the second cysteine, there is an ArgArg dipeptide which is identical to and aligns with Arg-147Arg-148 in P6. This dipeptide has a high probability of surface exposure in P6. Mutagenesis of the Arg-147Arg-148 to an AlaAla dipeptide in P6 abolished binding of MAb 3B9, demonstrating that it was either a portion of the epitope or important in the protein folding necessary for expression of this epitope. This study demonstrates that MAb 3B9 recognizes a conserved conformational determinant on the surface of H. influenzae that is composed of two discontinuous regions of P6.
P6是流感嗜血杆菌的一种外膜蛋白,其抗原性保守,被认为是未来流感嗜血杆菌疫苗的候选成分。P6含有一个可被单克隆抗体(MAb)3B9识别的表面暴露表位。在竞争性抑制酶联免疫吸附测定(ELISA)中,已证明该表位与P6特异性单克隆抗体7F3和4G4识别的表位不同。单克隆抗体3B9不与合成的P6特异性连续和重叠六聚体肽结合。制备的五个与P6序列相对应且具有高表面暴露可能性的肽并未抑制单克隆抗体3B9与P6的结合。针对其中一个名为SP66的肽的抗血清抑制了单克隆抗体3B9与P6的结合。针对P6的兔抗血清与P6的SP66区域中的连续六聚体肽Gly-87AsnThrAspGluArgGlyThr-94结合。该抗血清在竞争性抑制ELISA中抑制了P6与单克隆抗体3B9的结合。在苏氨酸-88和天冬酰胺-89残基处用组氨酸和丙氨酸替代的P6突变体仍能结合单克隆抗体3B9。单克隆抗体3B9与大肠杆菌OmpA和鼠伤寒沙门氏菌OmpA发生反应。P6与这些蛋白质的序列比较表明,SP66区域中负责结合的残基是甘氨酸-87、天冬氨酸-90或甘氨酸-93。巯基乙醇还原消除了单克隆抗体3B9与大肠杆菌OmpA和鼠伤寒沙门氏菌OmpA的结合。在这些蛋白质中,第二个半胱氨酸的紧邻下游有一个精氨酸-精氨酸二肽,它与P6中的精氨酸-147-精氨酸-148相同且对齐。该二肽在P6中具有高表面暴露可能性。将P6中的精氨酸-147-精氨酸-148突变为丙氨酸-丙氨酸二肽消除了单克隆抗体3B9的结合,表明它要么是表位的一部分,要么在该表位表达所需的蛋白质折叠中起重要作用。这项研究表明,单克隆抗体3B9识别流感嗜血杆菌表面由P6的两个不连续区域组成的保守构象决定簇。